Home page
The IOZK
The IOZK immunotherapy
Specialist knowledge
Latest news
Contact us
menu Menu

Article by Prof. Dr. Schirrmacher in the Viennese medical weekly "Skriptum"

2015-06-12

An article by Prof. Schirrmacher in the Viennese medical weekly "Skriptum"

Therapeutic use of oncolytic viruses

https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 IOZK https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg IOZK2015-06-12 17:06:232019-02-12 17:07:27Beitrag von Prof. Dr. Schirrmacher in der Wiener medizinischen Wochenschrift „Skriptum“

This might also interest you

IOZK analysis proves good tolerability of IOZK immunotherapy in diffuse intrinsic pontine glioma (DIPG)

Immunotherapy for prostate cancer: Canadian working group presents the current status

IOZK article in Austin Oncology Case Reports on cancer vaccines

Prof. Dr. Volker Schirrmacher publishes two groundbreaking review articles on immunotherapy

Prof. Dr. Schirrmacher publishes e-book: Harnessing Oncolytic Virus-mediated Antitumor Immunity

IOZK lecture: Modulated electro-hyperthermia in children with DIPG, ESHO conference, Charité Berlin

IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland

T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de

The IOZK

Philosophy
Team
Treatment center
Laboratories
Career
Arrival and overnight stay

The IOZK immunotherapy

IOZK immunotherapy
The IO-VAC® vaccine
Treatment procedure
Therapy costs
FAQ

IOZK Publications

The Complexity of Malignant Glioma Treatment
Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution
Neue IOZK Veröffentlichung zum Thema Liquid Biopsy

© 2025 IOZK Immun-Onkologisches Zentrum Köln

Imprint
Privacy policy
Cookie settings
Press

Nach oben scrollen